Position in OMER
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$3,556
-$361,112 QoQ
Shares Held
374
-98.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#152
of 172 holders
Holding Since
Jun 2022
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OMER Over Time
Shares Held
Position Value (USD)
Derivatives in OMER
reported options exposure · as of Jun 30, 2026CallValue
$381,351
CallShares
40,100
PutValue
$515,442
PutShares
54,200
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Walleye Capital LLC holds $328,656,270 across 126 Biotechnology names. OMER ranks #119 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
126,005 | $33,608,053 | |
| 2 | CYTK |
Cytokinetics Inc
|
239,728 | $20,422,428 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
288,233 | $16,492,692 | |
| 4 | IDYA |
IDEAYA Biosciences, Inc.
|
386,183 | $14,393,040 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
22,596 | $14,089,509 | |
| 6 | RARE |
Ultragenyx Pharmaceutical Inc.
|
334,854 | $11,180,775 | |
| 7 | TYRA |
Tyra Biosciences, Inc.
|
347,898 | $11,111,862 | |
| 8 | BCAX |
Bicara Therapeutics Inc.
|
353,226 | $10,487,279 |
All Filings in OMER
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $515,442 | 54,200 | Put | Sole | 2026-08-03 | |
| 2026-06-30 | $3,556 | 374 | Shares | Sole | 2026-08-03 | |
| 2026-06-30 | $381,351 | 40,100 | Call | Sole | 2026-08-03 | |
| 2026-03-31 | $364,668 | 34,533 | Shares | Sole | 2026-05-13 | |
| 2026-03-31 | $260,832 | 24,700 | Call | Sole | 2026-05-13 | |
| 2026-03-31 | $863,808 | 81,800 | Put | Sole | 2026-05-13 | |
| 2025-12-31 | $601,300 | 35,000 | Put | Sole | 2026-02-13 | |
| 2025-12-31 | $352,190 | 20,500 | Call | Sole | 2026-02-13 | |
| 2025-12-31 | $1,889,044 | 109,956 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $61,184 | 14,923 | Shares | Sole | 2025-11-14 | |
| 2025-09-30 | $76,260 | 18,600 | Call | Sole | 2025-11-14 | |
| 2025-06-30 | $8,700 | 2,900 | Put | Sole | 2025-08-13 | |
| 2025-06-30 | $81,900 | 27,300 | Call | Sole | 2025-08-13 | |
| 2025-06-30 | $6,855 | 2,285 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $72,336 | 8,800 | Call | Sole | 2025-05-14 | |
| 2025-03-31 | $23,838 | 2,900 | Put | Sole | 2025-05-14 | |
| 2024-09-30 | $234,388 | 59,040 | Shares | Sole | 2024-11-14 | |
| 2024-09-30 | $24,217 | 6,100 | Put | Sole | 2024-11-14 | |
| 2024-06-30 | $189,975 | 46,792 | Shares | Sole | 2024-08-14 | |
| 2023-09-30 | $87,600 | 30,000 | Put | Sole | 2023-11-21 | |
| 2022-06-30 | $371,244 | 134,998 | Shares | Sole | 2022-08-19 | |
| No filing history on record for this holder in this stock. | ||||||